Skip to main content

Coronavirus: Paxlovid

Question for Department of Health and Social Care

UIN 100630, tabled on 10 January 2022

To ask the Secretary of State for Health and Social Care, when the NHS plans to make Paxlovid available for the treatment of covid-19; and under what eligibility criteria.

Answered on

18 January 2022

We currently plan to deploy COVID-19 novel antivirals, including PF-07321332+ritonavir, co-packaged under the brand name Paxlovid, through the PANORAMIC national study. This will produce conclusive data on those would benefit most from antiviral treatments for COVID-19. We will provide an update in due course, including on whether any deployment outside the national study may take place.